Hemlibra 150 mg/mL Solution for Injection *

  • Company:

    Roche Registration GmbH
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.

  • EDM (Click to Download)

    Hemlibra (emicizumab): Laboratory Professional Guide

    Risk Minimisation Materials

  • EDM (Click to Download)

    Hemlibra (emicizumab): Healthcare Professional Guide Important Risk Minimisation Information for Healthcare Professionals

    Risk Minimisation Materials